316 related articles for article (PubMed ID: 31749778)
41. Genome Sequencing of
Zhang C; Ding W; Qin X; Ju J
Mar Drugs; 2019 Oct; 17(10):. PubMed ID: 31635159
[TBL] [Abstract][Full Text] [Related]
42. Engineering of Streptomyces lividans for heterologous expression of secondary metabolite gene clusters.
Ahmed Y; Rebets Y; Estévez MR; Zapp J; Myronovskyi M; Luzhetskyy A
Microb Cell Fact; 2020 Jan; 19(1):5. PubMed ID: 31918711
[TBL] [Abstract][Full Text] [Related]
43. Genome engineering for microbial natural product discovery.
Choi SS; Katsuyama Y; Bai L; Deng Z; Ohnishi Y; Kim ES
Curr Opin Microbiol; 2018 Oct; 45():53-60. PubMed ID: 29510374
[TBL] [Abstract][Full Text] [Related]
44.
Put H; Gerstmans H; Vande Capelle H; Fauvart M; Michiels J; Masschelein J
Nat Prod Rep; 2024 Mar; ():. PubMed ID: 38465694
[TBL] [Abstract][Full Text] [Related]
45. Discovery of a Phosphonoacetic Acid Derived Natural Product by Pathway Refactoring.
Freestone TS; Ju KS; Wang B; Zhao H
ACS Synth Biol; 2017 Feb; 6(2):217-223. PubMed ID: 28103011
[TBL] [Abstract][Full Text] [Related]
46. Synthetic biology advances and applications in the biotechnology industry: a perspective.
Katz L; Chen YY; Gonzalez R; Peterson TC; Zhao H; Baltz RH
J Ind Microbiol Biotechnol; 2018 Jul; 45(7):449-461. PubMed ID: 29915997
[TBL] [Abstract][Full Text] [Related]
47. Heterologous production of small molecules in the optimized Streptomyces hosts.
Myronovskyi M; Luzhetskyy A
Nat Prod Rep; 2019 Sep; 36(9):1281-1294. PubMed ID: 31453623
[TBL] [Abstract][Full Text] [Related]
48. Strategies for Engineering Natural Product Biosynthesis in Fungi.
Skellam E
Trends Biotechnol; 2019 Apr; 37(4):416-427. PubMed ID: 30316556
[TBL] [Abstract][Full Text] [Related]
49. Recent advances in the applications of promoter engineering for the optimization of metabolite biosynthesis.
Xu N; Wei L; Liu J
World J Microbiol Biotechnol; 2019 Jan; 35(2):33. PubMed ID: 30706208
[TBL] [Abstract][Full Text] [Related]
50. Marine Rare Actinobacteria: Isolation, Characterization, and Strategies for Harnessing Bioactive Compounds.
Dhakal D; Pokhrel AR; Shrestha B; Sohng JK
Front Microbiol; 2017; 8():1106. PubMed ID: 28663748
[TBL] [Abstract][Full Text] [Related]
51. Novel Alkaloids from Marine Actinobacteria: Discovery and Characterization.
De Rop AS; Rombaut J; Willems T; De Graeve M; Vanhaecke L; Hulpiau P; De Maeseneire SL; De Mol ML; Soetaert WK
Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049861
[TBL] [Abstract][Full Text] [Related]
52. Engineering of the Filamentous Fungus
Guzmán-Chávez F; Zwahlen RD; Bovenberg RAL; Driessen AJM
Front Microbiol; 2018; 9():2768. PubMed ID: 30524395
[No Abstract] [Full Text] [Related]
53. Engineering Salinispora tropica for heterologous expression of natural product biosynthetic gene clusters.
Zhang JJ; Moore BS; Tang X
Appl Microbiol Biotechnol; 2018 Oct; 102(19):8437-8446. PubMed ID: 30105571
[TBL] [Abstract][Full Text] [Related]
54. A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators.
Martinet L; Naômé A; Deflandre B; Maciejewska M; Tellatin D; Tenconi E; Smargiasso N; de Pauw E; van Wezel GP; Rigali S
mBio; 2019 Aug; 10(4):. PubMed ID: 31409675
[TBL] [Abstract][Full Text] [Related]
55. Challenges and advances in genetic manipulation of filamentous actinomycetes - the remarkable producers of specialized metabolites.
Musiol-Kroll EM; Tocchetti A; Sosio M; Stegmann E
Nat Prod Rep; 2019 Sep; 36(9):1351-1369. PubMed ID: 31517370
[TBL] [Abstract][Full Text] [Related]
56. Mini review: Genome mining approaches for the identification of secondary metabolite biosynthetic gene clusters in
Lee N; Hwang S; Kim J; Cho S; Palsson B; Cho BK
Comput Struct Biotechnol J; 2020; 18():1548-1556. PubMed ID: 32637051
[No Abstract] [Full Text] [Related]
57. Tapping Into Actinobacterial Genomes for Natural Product Discovery.
Singh TA; Passari AK; Jajoo A; Bhasin S; Gupta VK; Hashem A; Alqarawi AA; Abd Allah EF
Front Microbiol; 2021; 12():655620. PubMed ID: 34239507
[TBL] [Abstract][Full Text] [Related]
58. Renewed interests in the discovery of bioactive actinomycete metabolites driven by emerging technologies.
Ossai J; Khatabi B; Nybo SE; Kharel MK
J Appl Microbiol; 2022 Jan; 132(1):59-77. PubMed ID: 34265147
[TBL] [Abstract][Full Text] [Related]
59. Rational construction of genome-minimized
Li H; Gao S; Shi S; Zhao X; Ye H; Luo Y
Synth Syst Biotechnol; 2024 Sep; 9(3):600-608. PubMed ID: 38774831
[No Abstract] [Full Text] [Related]
60. Hosts engineering and
Zhang H; Guo L; Su Y; Wang R; Yang W; Mu W; Xuan L; Huang L; Wang J; Gao W
Crit Rev Biotechnol; 2023 Aug; ():1-19. PubMed ID: 37574211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
